There are 2867 resources available
355P - The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer (mCRC) patients: A Turkish oncology group (TOG) study
Presenter: Aykut Demirkiran
Session: Poster session 07
356P - Biallelic MUTYH germline inactivation in patients with colon polyposis and subjects with sporadic colorectal cancer
Presenter: Evgeny Imyanitov
Session: Poster session 07
357P - Novel potential predictive biomarker to immunotherapy (Io) treatment in metastatic colorectal cancer (mCRC) patients: The role of the VHIO immune gene-expression signature (VIGex)
Presenter: Nadia Saoudi Gonzalez
Session: Poster session 07
358P - Analysis of microbiome signatures in plasma for early CRC detection
Presenter: James Kinross
Session: Poster session 07
359P - Analysis of TMB and tumor microenvironment in Polymerase epsilon (POLE) deficient colorectal cancer
Presenter: Weiqun Lu
Session: Poster session 07
360P - Epigenetic engineering on CDX2 allows to determine the interplaying consequences with other genetic and transcriptomic events in colorectal cancer
Presenter: Francisco Gimeno-Valiente
Session: Poster session 07
361P - Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER
Presenter: Christina Wu
Session: Poster session 07
362P - Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation
Presenter: Jayesh Desai
Session: Poster session 07
363P - Prevalence of acquired (acq) genomic alterations (GAs) after progression on anti-EGFR mAb (EGFRi) based therapy in metastatic colorectal cancer (mCRC): A systematic review and meta-analysis
Presenter: Kanwal Raghav
Session: Poster session 07
364P - Prevalence, treatment and survival of NTRK gene fusions in microsatellite instable metastatic colorectal cancer patients
Presenter: Suzanna Schraa
Session: Poster session 07